Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Diabete & Metabolisme|May 1, 1989
Fructose is as good a fuel as glucose for exercise in normal subjectsG Slama, J Boillot, I Hellal, et al.
The American Journal of Clinical Nutrition|June 1, 1996
Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolismJ Luo, S W Rizkalla, C Alamowitch, et al.
The American Journal of Medicine|July 5, 2005
A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteriaThomas G Slama, Alpesh Amin, Stephen A Brunton, et al.
Diabetes & Metabolism|February 15, 2001
[Considerations on delocalized HbA1c assays]M Bordas-Fonfrède, J Sélam, J Goudable, et al.
The Journal of Bone and Joint Surgery. American Volume|January 1, 1994
Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolinD R Mauerhan, C L Nelson, D L Smith, et al.
Medicine|March 1, 1983
Pericarditis as a manifestation of histoplasmosis during two large urban outbreaksL J Wheat, L Stein, B C Corya, et al.
Diabetes & Metabolism|November 18, 2006
Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative studyL Dufaitre-Patouraux, J P Riveline, E Renard, et al.
Annals of Internal Medicine|November 1, 1982
The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreakJ Wheat, M L French, R B Kohler, et al.
Annales De Biologie Clinique|August 10, 2000
[Hemoglobin A1C determination and hemoglobinopathies: problems and strategies]P Gillery, G Hue, M Bordas-Fonfrède, et al.
Diabetes & Metabolism|September 28, 1999
HBA1c: clinical and biological agreement for standardization of assay methods. Report by the experts of ALFEDIAM (Association de Langue Française pour lEtude du Diabète et des Maladies Métabolique) and SFBC (Société Française de Biologie Clinique)P Gillery, M Bordas-Fonfrède, J P Chapelle, et al.
Pageof 21